We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Hepregen Launches First Dog HepatoPac® Assay Kit
Product News

Hepregen Launches First Dog HepatoPac® Assay Kit

Hepregen Launches First Dog HepatoPac® Assay Kit
Product News

Hepregen Launches First Dog HepatoPac® Assay Kit


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Hepregen Launches First Dog HepatoPac® Assay Kit"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Hepregen Corporation has announced the commercial launch of the company's first dog HepatoPac® kit designed specifically for metabolite identification and profiling applications. Each kit contains one or more standard 24-well tissue culture plates featuring uniquely configured micro-patterned dog liver cells co-cultured with specially selected stromal cells that support the highest level of performance observed in Hepregen's micro-patterned co-culture platform.

The dog liver cells (hepatocytes) on these plates mirror the behavior of liver cells in live animals, enabling scientists to generate data that can be useful for evaluation of the metabolism of chemical agents, including drug candidates, improving the design of preclinical experiments.

The remarkable flexibility of Hepregen's micro-patterned HepatoPac® platform allowed Hepregen scientists to develop a dog product that provides investigators with uniquely stable canine hepatocytes. The tissue culture maintains functionality and morphology for weeks, enabling experiments not previously possible.

Dr. Vincent Zurawski, Hepregen's Chief Executive Officer stated, "This new dog product provides another HepatoPac® application-directed kit serving the drug- and chemical-metabolism market. The unprecedented performance of the kit is enabled by a proprietary species-specific set of features that may be adaptable to all live-cell, in vitro products that contain primary dog hepatocytes. The introduction of our dog kit provides customers with a complete set of products relevant to drug development: human, monkey, rat and now dog HepatoPac® kits for metabolite identification and profiling."

Advertisement